<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01138865</url>
  </required_header>
  <id_info>
    <org_study_id>SKS/CPAP-OSAS/2009</org_study_id>
    <nct_id>NCT01138865</nct_id>
  </id_info>
  <brief_title>Effect of CPAP on Biomarkers in Patients With OSA</brief_title>
  <acronym>CPAP</acronym>
  <official_title>Effect of Continuous Positive Airway Pressure (CPAP) on Cardiovascular Biomarkers in Patients With Obstructive Sleep Apnea.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>All India Institute of Medical Sciences, New Delhi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>All India Institute of Medical Sciences, New Delhi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      CPAP, the standard treatment for Obstructive sleep apnea syndrome (OSAS) that reduces sleep
      fragmentations and neurocognitive deficit in OSAS may also have a key role in reduction of
      cardiovascular, mortality risks in the same patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive sleep apnea (OSA) is a condition in which there is collapse of the upper airway
      during sleep, as a result of which there is a decrease or complete cessation of airflow. This
      leads to repeated episodes of hypoxia during sleep and sleep fragmentation. It is a highly
      prevalent though under-recognized clinical problem.There is increasing evidence that
      inflammation plays important role in development of cardiovascular complications in patients
      with OSA.

      Continuous positive airway pressure (CPAP) is the standard treatment for OSA with significant
      symptoms.However, it is a costly treatment option and poor compliance is an important
      limiting factor. CPAP treatment has been shown to improve the daytime somnolence and
      neurocognitive function in people with OSAS. However, its effect on cardiovascular biomarkers
      in people with OSAS has not been satisfactorily assessed.

      This study aims to assess the effect of CPAP treatment on cardiovascular biomarkers in OSA.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of CPAP therapy on blood pressure</measure>
    <time_frame>7 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of CPAP therapy on insulin resistance</measure>
    <time_frame>7months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of CPAP therapy on plasma hs-CRP</measure>
    <time_frame>7months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of CPAP therapy on lipid profile</measure>
    <time_frame>7months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of CPAP therapy on urinary albumin-creatinine ratio</measure>
    <time_frame>7months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of CPAP on anthropometric parameters</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of CPAP on visceral fat and other imagings</measure>
    <time_frame>3months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of CPAP on carotid intima medical thickness</measure>
    <time_frame>3months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of CPAP on adipokines and oxidative stress markers</measure>
    <time_frame>3months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of CPAP on inflammatory cytokine levels.</measure>
    <time_frame>3months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Device: AutoSet Spirit--Wash--Modified-AutoSet Spirit 3 months of therapeutic CPAP (auto-titrating CPAP) followed by 3 months of non-therapeutic sham-CPAP with 1 month of wash-out in between</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>3 months of non-therapeutic sham-CPAP followed by 3 months of therapeutic CPAP (auto-titrating CPAP) with 1 month of wash-out in between</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AutoSet Spirit--Wash--Modified-AutoSet Spirit</intervention_name>
    <description>3 months of therapeutic CPAP (auto-titrating CPAP) followed by 3 months of non-therapeutic sham-CPAP with 1 month of wash-out in between</description>
    <arm_group_label>1</arm_group_label>
    <other_name>AutoSet Spirit(TM), ResMed India Ltd.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Modified-AutoSet Spirit--Wash-AutoSet Spirit</intervention_name>
    <description>3 months of non-therapeutic sham-CPAP followed by 3 months of therapeutic CPAP (auto-titrating CPAP) with 1 month of wash-out in between</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Modified-AutoSet Spirit(TM), ResMed India Ltd.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The 1st part of the study will include

          1. males and females, aged 30-65 years,

          2. with AHI &gt;5 and excessive daytime sleepiness

          3. na√Øve to CPAP treatment.

          4. Subjects from first part of the study who have moderately severe OSAS and have never
             received treatment for OSA,diabetes mellitus and hypertension

        Exclusion Criteria:

          1. Hypothyroidism

          2. Chronic renal failure

          3. Chronic liver disease

          4. Chronic lung disease

          5. Known systemic inflammatory diseases (lupus , sarcoidosis and other connective tissue
             disorders),

          6. Use of drugs that influence urinary protein excretion (eg. steroids, lithium, NSAIDS,
             ACE inhibitors/Angiotensin Receptor Blockers etc.)

          7. Immune deficiency conditions

          8. Pregnancy

          9. Active menstruation at time of sampling

         10. Macroalbuminuria (aACR&gt;300mg/g),

         11. Patients of coronary artery disease and left ventricular dysfunction

         12. Not on treatment for hypertension, diabetes mellitus or dyslipidemia

         13. Long lasting hypertension or diabetes mellitus (more than 5 years after diagnosis)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Surendra K Sharma, MD,Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>All India Institute of Medical Sciences, New Delhi</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Surendra K Sharma, MD, Ph.D</last_name>
    <phone>91-11-26594415</phone>
    <email>sksharma@aiims.ac.in</email>
  </overall_contact>
  <location>
    <facility>
      <name>All India Institute of Medical Sciences</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110029</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Surendra K Sharma, MD, Ph.D</last_name>
      <phone>91-11-26594415</phone>
      <email>sksharma@aiims.ac.in</email>
    </contact>
    <investigator>
      <last_name>Surender K Sharma, MD, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>M Irshad, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vishubhatla Sreenivas, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ramakrishnan Lakshmy, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manish Soneja, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Atin Kumar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Priya Jagia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Deepak Damodaran, M.B.B.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2010</study_first_submitted>
  <study_first_submitted_qc>June 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2010</study_first_posted>
  <last_update_submitted>June 21, 2013</last_update_submitted>
  <last_update_submitted_qc>June 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>All India Institute of Medical Sciences, New Delhi</investigator_affiliation>
    <investigator_full_name>S.K.SHARMA</investigator_full_name>
    <investigator_title>Professor and Haed</investigator_title>
  </responsible_party>
  <keyword>Obstructive sleep apnea</keyword>
  <keyword>Cytokine levels</keyword>
  <keyword>Insulin resistance</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Dyslipidemia</keyword>
  <keyword>Albumin-creatinine ratio</keyword>
  <keyword>Continuous positive airway pressure (CPAP)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

